We are a medical device company that is pioneering the use of flexible instruments and robotics to improve the outcomes of minimally invasive surgery. Specifically, we are addressing the challenges presented to patients, surgeons, hospitals and payers in laparoscopy and robotic surgery today. The company is developing a robotic assisted surgical system called the SurgiBot™. The system utilizes flexible instruments through articulating channels controlled directly by the surgeon, with robotic assistance, at the patient's bedside. The flexible nature of the system allows for multiple instruments to be introduced and deployed through a singlesite. The system also integrates 3-D vision technology which we believe will enhance the quality of visualization of key structures and will support complex surgical tasks.
On September 3, 2013, TransEnterix merged with SafeStitch, a medical device company focused on the development of technologies that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery.